|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
149,990,000 |
Market
Cap: |
137.98(M) |
Last
Volume: |
394,168 |
Avg
Vol: |
182,850 |
52
Week Range: |
$0.9199 - $0.9199 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Lineage Cell Therapeutics is a clinical-stage biotechnology company developing cell therapies. Co. has several allogeneic cell therapy programs in development: OpRegen®, a retinal pigment epithelium cell replacement therapy for the treatment of advanced dry age-related macular degeneration with geographic atrophy; OPC1, an oligodendrocyte progenitor cell therapy for spinal cord injuries; VAC, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells; and other product candidates in preclinical development covering a range of therapeutic areas and target tissues or organs. Co. has rights to HyStem, a patented biomaterial that mimics naturally occurring extracellular matrix.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
96,155 |
6,836,925 |
6,836,925 |
6,836,925 |
Total Buy Value |
$100,001 |
$7,110,902 |
$7,110,902 |
$7,110,902 |
Total People Bought |
1 |
3 |
3 |
3 |
Total Buy Transactions |
1 |
4 |
4 |
4 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Farrell Stephen C |
Director |
|
2015-11-06 |
4 |
B |
$3.83 |
$191,500 |
D/D |
50,000 |
97,450 |
2.39 |
- |
|
Russell Angus C. |
Director |
|
2015-11-06 |
4 |
B |
$3.83 |
$191,500 |
D/D |
50,000 |
67,500 |
2.39 |
- |
|
Kingsley Alfred D |
See Remarks |
|
2015-11-06 |
4 |
S |
$3.83 |
$383,000 |
D/D |
(100,000) |
5,938,055 |
|
- |
|
Bradsher Neal C |
Director |
|
2015-10-02 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
21,864,396 |
|
- |
|
Bradsher Neal C |
Director |
|
2015-10-02 |
4 |
A |
$3.19 |
$5,104,000 |
D/D |
1,600,000 |
21,864,396 |
|
- |
|
Bradsher Neal C |
Director |
|
2015-09-14 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
20,264,396 |
|
- |
|
Bradsher Neal C |
Director |
|
2015-09-14 |
4 |
A |
$3.29 |
$8,000,000 |
D/D |
2,431,611 |
20,264,396 |
|
- |
|
Andrews Deborah J |
Director |
|
2015-08-26 |
4 |
B |
$2.82 |
$5,640 |
D/D |
2,000 |
2,000 |
2.39 |
- |
|
Cartt Stephen Lahue |
Director |
|
2015-08-18 |
4 |
B |
$2.90 |
$49,832 |
D/D |
17,200 |
155,125 |
2.39 |
- |
|
Cartt Stephen Lahue |
Director |
|
2015-08-17 |
4 |
B |
$2.83 |
$111,478 |
D/D |
39,400 |
137,925 |
2.39 |
- |
|
Cartt Stephen Lahue |
Director |
|
2015-08-14 |
4 |
B |
$2.65 |
$48,756 |
D/D |
18,400 |
98,525 |
2.39 |
- |
|
Segall Judith |
Vice President & Secretary |
|
2015-01-05 |
5/A |
GD |
$4.11 |
$6,165 |
D/D |
1,500 |
593,145 |
|
- |
|
Russell Angus C. |
Director |
|
2014-12-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
17,500 |
|
- |
|
Cartt Stephen Lahue |
Director |
|
2014-11-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
80,125 |
|
- |
|
Farrell Stephen C |
Director |
|
2014-10-08 |
4 |
B |
$3.12 |
$99,996 |
D/D |
32,050 |
47,450 |
2.39 |
- |
|
Schlachet David |
Director |
|
2014-10-08 |
4 |
B |
$3.12 |
$99,996 |
I/I |
32,050 |
32,050 |
2.1 |
- |
|
Bradsher Neal C |
Director |
|
2014-10-08 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
17,832,785 |
|
- |
|
Bradsher Neal C |
Director |
|
2014-10-08 |
4 |
A |
$3.12 |
$12,606,432 |
D/D |
4,040,523 |
17,832,785 |
|
- |
|
Mulroy Michael H. |
Director |
|
2014-10-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
32,550 |
|
- |
|
Bradsher Neal C |
Director |
|
2014-07-22 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
13,792,262 |
2.17 |
- |
|
Bradsher Neal C |
Director |
|
2014-07-22 |
4 |
B |
$2.65 |
$980,500 |
D/D |
370,000 |
13,792,262 |
3.92 |
- |
|
Peabody Robert |
Sr. VP, COO, and CFO |
|
2014-07-22 |
4 |
S |
$2.65 |
$265,000 |
D/D |
(100,000) |
315,777 |
|
- |
|
Peabody Robert |
Sr. VP, COO, and CFO |
|
2014-07-22 |
4 |
S |
$2.65 |
$265,000 |
D/D |
(100,000) |
315,777 |
|
- |
|
West Michael D |
Chief Executive Officer |
|
2014-07-22 |
4 |
S |
$2.65 |
$715,500 |
D/D |
(270,000) |
875,987 |
|
- |
|
Peabody Robert |
Sr. VP, COO, and CFO |
|
2014-07-21 |
4 |
D |
$2.65 |
$237,501 |
D/D |
(89,623) |
415,777 |
|
- |
|
194 Records found
|
|
Page 7 of 8 |
|
|